News · Edaily·

Genematrix Begins Phase 1 Trial of Domestically Developed Hepatitis A Vaccine

Predicted impact: Medium

Phase 1 start for a hepatitis A vaccine; early-stage, small company with market value about 29.6 billion won.

Comments

Sign in to comment

No comments yet. Start the conversation.

Comments are people's own views. Nothing here is financial advice.

Genematrix Begins Phase 1 Trial of Domestically… | JONBUR